Levocarnitine and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Levocarnitine (levocarnitine), especially for people who are male, 10-19 old, also take Amlodipine, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Cellulitis when taking Levocarnitine. It is created by eHealthMe based on reports of 3,299 people who have side effects when taking Levocarnitine from the FDA, and is updated regularly.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,080 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 19, 2026

3,299 people reported to have side effects when taking Levocarnitine.
Among them, 28 people (0.85%) have Cellulitis.

Among these 28 people:

What is the gender of people who have Cellulitis when taking Levocarnitine? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Cellulitis when taking Levocarnitine? *

What are other drugs people take besides Levocarnitine? *

What are other side effects people have besides Cellulitis? *

Febrile Neutropenia (fever with reduced white blood cells): 17 people, 60.71%
Pneumonia: 10 people, 35.71%
Septic Shock (shock due to blood infection): 8 people, 28.57%
Hyperglycemia (high blood sugar): 8 people, 28.57%
Parainfluenzae Virus Infection: 8 people, 28.57%
Myositis (inflammation of the muscles): 8 people, 28.57%
Escherichia Bacteraemia (presence of bacteria escherichia coli in the blood): 8 people, 28.57%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 7 people, 25.00%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 6 people, 21.43%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 6 people, 21.43%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 11 people, 39.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.71%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.71%
Tonsillitis (inflammation of tonsil): 2 people, 7.14%
Spinal Muscular Atrophy (wasting of spinal muscles): 2 people, 7.14%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 7.14%
Blood Pressure Abnormal: 2 people, 7.14%
Viral Vasculitis (inflammation of blood vessels caused by viruses): 1 person, 3.57%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 3.57%
Neuralgia (pain in one or more nerves): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Levocarnitine and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levocarnitine:

Levocarnitine (3,332 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,080 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on levocarnitine (the active ingredients of Levocarnitine) and Levocarnitine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.